Keeps Biopharma Inc. (256940) Price & Analysis
256940 Stock Chart & Stats
₩5,100.00-₩210.00(-3.95%)
At close: 4:00 PM EDT
- Day’s Range
- KRW 4,980.00 - KRW 5,320.00
- 52-Week Range
- KRW 4,980.00 - KRW 12,880.00
- Previous Close
- KRW 5,310.00
- Volume
- N/A
- Average Volume (3M)
- 44.57K
- Market Cap
- KRW 102.40B
- Enterprise Value
- KRW 209.08B
- Total Cash (Recent Filing)
- N/A
- Total Debt (Recent Filing)
- N/A
- Price to Earnings (P/E)
- ―
- Beta
- 0.10
- Next Earnings
- Nov 12, 2026
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
256940 FAQ
What was Keeps Biopharma Inc.’s price range in the past 12 months?
Keeps Biopharma Inc. lowest stock price was ₩4980.00 and its highest was ₩12880.00 in the past 12 months.
What is Keeps Biopharma Inc.’s market cap?
Keeps Biopharma Inc.’s market cap is ₩102.40B.
When is Keeps Biopharma Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Keeps Biopharma Inc.’s earnings last quarter?
Keeps Biopharma Inc. released its earnings results on Aug 14, 2026. The company reported -₩436.502 earnings per share for the quarter.
Is Keeps Biopharma Inc. overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Keeps Biopharma Inc. pay dividends?
Keeps Biopharma Inc. does not currently pay dividends.
What is Keeps Biopharma Inc.’s EPS estimate?
Keeps Biopharma Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Keeps Biopharma Inc. have?
Keeps Biopharma Inc. has 20,078,148 shares outstanding.
What happened to Keeps Biopharma Inc.’s price movement after its last earnings report?
Keeps Biopharma Inc. reported an EPS of -₩436.502 in its last earnings report. Following the earnings report the stock price went up 1.153%.
Which hedge fund is a major shareholder of Keeps Biopharma Inc.?
Currently, no hedge funds are holding shares in KR:256940
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Keeps Biopharma Inc. (256940) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 5 | 3 | 14 |
| Technical Analysis | 5 | 3 | 2 |
| Moving Averages | 0 | 0 | 12 |